(Circulation. 1999;99:2157-2163.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Essential Role of Inducible Nitric Oxide Synthase in Monophosphoryl Lipid A–Induced Late Cardioprotection
Evidence From Pharmacological Inhibition and Gene Knockout Mice
From the Division of Cardiology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Correspondence to Dr Rakesh C. Kukreja, Eric Lipman Professor, Division of Cardiology, Box 980281, Medical College of Virginia, Richmond, VA 23298. E-mail rakesh{at}hsc.vcu.edu
Background—Monophosphoryl lipid A (MLA), a nontoxic analogue of endotoxin, is a pharmacological agent that is known to have anti-ischemic effects. Mechanisms involved with the cardioprotection are still unclear. A role for inducible nitric oxide synthase (iNOS) was recently proposed. We tested this hypothesis using S-methylisothiourea (SMT), one of the specific pharmacological inhibitors of iNOS, as well as iNOS gene knockout mice.
Methods and Results—Adult male ICR or B6,129 mice were pretreated with either MLA 35 or 350 µg/kg IP (MLA35 or MLA350) or vehicle 24 hours before global ischemia/reperfusion, which was carried out in a Langendorff isolated perfused heart model (n=8 to 9 per group). Another group of MLA350 mice received SMT 3 mg/kg IP 30 minutes before heart perfusion. Ventricular contractile function and heart rate were not different between the groups during the preischemia and reperfusion periods (P>0.05). Preischemic basal coronary flow was significantly increased in all MLA350 but not MLA35 mice. Myocardial infarct size was reduced significantly, from 26.9±2.9% of risk area in vehicle-treated mice to 13.5±2.4% in the MLA350 group (mean±SEM, P<0.05). This reduction in infarct size was accompanied by augmented nitrite/nitrate accumulation, from 0.23±0.05 nmol/mg protein in the vehicle group to 0.97±0.27 nmol/mg protein in MLA350 mice (P<0.01). Infarct size increased significantly, to 22.2±2.8% after treatment with SMT in the MLA350 group. Furthermore, MLA350 failed to reduce infarct size in iNOS knockout mice (25.5±3.6%).
Conclusions—These results demonstrate a direct association of infarct size reduction with increased NO production with MLA350. An obligatory role for iNOS in mediating the cardioprotective effect induced by MLA was confirmed with the pharmacological inhibition and gene knockout mice.
Key Words: ischemia • reperfusion • myocardial infarction • pharmacology • nitric oxide
This article has been cited by other articles:
 |
|
 |
|
  A. Das, F. N. Salloum, L. Xi, Y. J. Rao, and R. C. Kukreja ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1236 - H1243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Yin, F. N. Salloum, and R. C. Kukreja A Novel Role of MicroRNA in Late Preconditioning: Upregulation of Endothelial Nitric Oxide Synthase and Heat Shock Protein 70 Circ. Res., March 13, 2009; 104(5): 572 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Das, L. Xi, and R. C. Kukreja Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3{beta} J. Biol. Chem., October 24, 2008; 283(43): 29572 - 29585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xi, A. Das, Z.-Q. Zhao, V. F. Merino, M. Bader, and R. C. Kukreja Loss of Myocardial Ischemic Postconditioning in Adenosine A1 and Bradykinin B2 Receptors Gene Knockout Mice Circulation, September 30, 2008; 118(14_suppl_1): S32 - S37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maffei, A. Di Pardo, R. Carangi, P. Carullo, R. Poulet, M. T. Gentile, C. Vecchione, and G. Lembo Nebivolol Induces Nitric Oxide Release in the Heart Through Inducible Nitric Oxide Synthase Activation Hypertension, October 1, 2007; 50(4): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Hermonat, D. Li, B. Yang, and J. L. Mehta Mechanism of action and delivery possibilities for TGF{beta}1 in the treatment of myocardial ischemia Cardiovasc Res, May 1, 2007; 74(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury Circ. Res., January 6, 2006; 98(1): 133 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Harder, C. Contaldo, J. Klenk, A. Banic, S. M. Jakob, and D. Erni Preconditioning with Monophosphoryl Lipid A Improves Survival of Critically Ischemic Tissue Anesth. Analg., June 1, 2005; 100(6): 1786 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Di Napoli, A. A. Taccardi, A. Grilli, M. A. De Lutiis, A. Barsotti, M. Felaco, and R. De Caterina Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts Cardiovasc Res, June 1, 2005; 66(3): 462 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Das, L. Xi, and R. C. Kukreja Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis: ESSENTIAL ROLE OF NITRIC OXIDE SIGNALING J. Biol. Chem., April 1, 2005; 280(13): 12944 - 12955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, M. Taher, C. Yin, F. Salloum, and R. C. Kukreja Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1{alpha} and AP-1 and iNOS signaling Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2369 - H2375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, C. Yin, L. Xi, and R. C. Kukreja Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2070 - H2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xia, R. Xia, H.-T. Lan, T. Luo, Q.-Z. Tang, Z.-Y. Xia, and X.-Y. Liu Systemic ischemic preconditioning plus hemodilution enhanced early functional recovery of reperfused heart in the rabbits Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 528 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, N. Ahmad, M. Kudo, and M. Ashraf Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1125 - H1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Tang, Y.-T. Xuan, Y. Zhu, G. Shirk, and R. Bolli Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1273 - H1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marfella, C. Di Filippo, K. Esposito, F. Nappo, E. Piegari, S. Cuzzocrea, L. Berrino, F. Rossi, D. Giugliano, and M. D'Amico Absence of Inducible Nitric Oxide Synthase Reduces Myocardial Damage During Ischemia Reperfusion in Streptozotocin-Induced Hyperglycemic Mice Diabetes, February 1, 2004; 53(2): 454 - 462. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, Y. Guo, Y.-T. Xuan, C. J. Lowenstein, S. C. Stevenson, S. D. Prabhu, W.-J. Wu, Y. Zhu, and R. Bolli Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase-2-Dependent Mechanism Circ. Res., April 18, 2003; 92(7): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Salloum, C. Yin, L. Xi, and R. C. Kukreja Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase-Dependent Pathway in Mouse Heart Circ. Res., April 4, 2003; 92(6): 595 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Tang, E. Kodani, H. Takano, M. Hill, K. Shinmura, T. M. Vondriska, P. Ping, and R. Bolli Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1441 - H1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Cross, E. G. Kranias, E. Murphy, and C. Steenbergen Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H683 - H690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Brunner, R. Maier, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Cardiovasc Res, January 1, 2003; 57(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Wang, C. Sato, K. Mizoguchi, Y. Yamashita, M. Oe, and H. Maeta Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase Cardiovasc Res, October 1, 2002; 56(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ockaili, F. Salloum, J. Hawkins, and R. C. Kukreja Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial KATP channels in rabbits Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1263 - H1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Laude, P. Beauchamp, C. Thuillez, and V. Richard Endothelial protective effects of preconditioning Cardiovasc Res, August 15, 2002; 55(3): 466 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Cross, E. Murphy, and C. Steenbergen Ca2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H481 - H489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, D. Tekin, E. Gursoy, F. Salloum, J. E. Levasseur, and R. C. Kukreja Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H5 - H12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H339 - H345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Zhang, B. C. McPherson, H. Liu, T. Baman, S. S. McPherson, P. Rock, and Z. Yao Role of Nitric-Oxide Synthase, Free Radicals, and Protein Kinase C delta in Opioid-Induced Cardioprotection J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1012 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hattori, H. Otani, N. Maulik, and D. K. Das Pharmacological preconditioning with resveratrol: role of nitric oxide Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1988 - H1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R Cross, E. Murphy, W. J Koch, and C. Steenbergen Male and female mice overexpressing the {beta}2-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide Cardiovasc Res, February 15, 2002; 53(3): 662 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Kim, Y.-K. Kim, G. Takagi, C.-H. Huang, Y.-J. Geng, and S. F. Vatner Enhanced iNOS function in myocytes one day after brief ischemic episode Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H423 - H428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M Bell, C. C.T Smith, and D. M Yellon Nitric oxide as a mediator of delayed pharmacological (A1 receptor triggered) preconditioning; is eNOS masquerading as iNOS? Cardiovasc Res, February 1, 2002; 53(2): 405 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Di Napoli, A. Antonio Taccardi, A. Grilli, R. Spina, M. Felaco, A. Barsotti, and R. De Caterina Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts Cardiovasc Res, August 1, 2001; 51(2): 283 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Ockaili, P. Bhargava, and R. C. Kukreja Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2406 - H2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bolli The Late Phase of Preconditioning Circ. Res., November 24, 2000; 87(11): 972 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Finkel Nitric Oxide and Viral Cardiomyopathy Circulation, October 31, 2000; 102(18): 2162 - 2164. [Full Text] [PDF]
|
|
|
|
|
|
T. Zhao, L. Xi, J. Chelliah, J. E. Levasseur, and R. C. Kukreja Inducible Nitric Oxide Synthase Mediates Delayed Myocardial Protection Induced by Activation of Adenosine A1 Receptors : Evidence From Gene-Knockout Mice Circulation, August 22, 2000; 102(8): 902 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kanno, P. C. Lee, Y. Zhang, C. Ho, B. P. Griffith, L. L. Shears II, and T. R. Billiar Attenuation of Myocardial Ischemia/Reperfusion Injury by Superinduction of Inducible Nitric Oxide Synthase Circulation, June 13, 2000; 101(23): 2742 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, F. Salloum, D. Tekin, N. C. Jarrett, and R. C. Kukreja Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2418 - H2424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ockaili, V. R. Emani, S. Okubo, M. Brown, K. Krottapalli, and R. C. Kukreja Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2425 - H2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Zhao, M. M. Taher, K. C. Valerie, and R. C. Kukreja p38 Triggers Late Preconditioning Elicited by Anisomycin in Heart: Involvement of NF-{kappa}B and iNOS Circ. Res., November 9, 2001; 89(10): 915 - 922. [Abstract] [Full Text] [PDF]
|
|